Molecular characterization of HER2-positive (HER2+) metastatic gastric and gastro-esophageal junction cancer patients (mGC): Identification of resistance mechanisms to trastuzumab-based therapy (TTZ) Meeting Abstract
| Authors: | Alsina, M.; Hierro, C.; Sastre, J.; Guardeno, R.; Lopez, C.; Pineda, E.; Aranda, E.; Manzano, J. L.; Galan, M.; Longo, F.; Visa, L.; Landolfi, S.; Jimenez, J.; Sperinde, J.; Pandiella, A.; Tabernero, J.; Hernandez-Losa, J.; Arribas, J.; Scaltriti, M.; Nuciforo, P. |
| Abstract Title: | Molecular characterization of HER2-positive (HER2+) metastatic gastric and gastro-esophageal junction cancer patients (mGC): Identification of resistance mechanisms to trastuzumab-based therapy (TTZ) |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi213 |
| Language: | English |
| ACCESSION: | WOS:000393912500635 |
| DOI: | 10.1093/annonc/mdw371.21 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 629P -- Source: Wos |
